Icosavax, Inc.
ICVX

$769.04 M
Marketcap
$15.31
Share price
Country
$-0.14
Change (1 day)
$16.11
Year High
$4.75
Year Low
Categories

Icosavax, Inc., a biopharmaceutical company, develops vaccines against infectious diseases. The company, with the help of its virus-like particle (VLP) platform technology, focuses primarily on life-threatening respiratory diseases. Its products in pipeline include IVX-121, a vaccine candidate with RSV target and is under Phase 1/1b clinical trial; IVX-A12, a respiratory syncytial virus (RSV) monovalent antigen candidate with RSV/human metapneumovirus (hMPV) bivalent target indication; IVX-241, a vaccine candidate with hMPV target; and IVX-411, an original receptor binding domain (RBD) sequence antigen with SARS-CoV-2 target indication and is under Phase 1/2 clinical trial. The company was incorporated in 2017 and is headquartered in Seattle, Washington.

marketcap

Stock price history for Icosavax, Inc. (ICVX)

Highest end of day price: $40.25 USD on 2021-08-23

Lowest end of day price: $2.32 USD on 2022-11-14

Stock price history of Icosavax, Inc. from 2021 to 2024